B. Mihaylova
Economics and Econometrics · 2010–2023
A researcher in the Science corpus: 7 papers; trusts 4 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Economics and Econometrics — 44 citations into it; #20,398 of 23,481 by trust here, #10,133 by citations
- General Health Professions — 9 citations into it; #3,761 of 4,781 by trust here, #4,328 by citations
- Statistics and Probability — 9 citations into it
Whom B. Mihaylova trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- N. Duan
- S. Thompson
- H. Friedl
- A. Basu
- N. Cooper
- Janet Tooze
- A. Sutton
- Alan M. Zaslavsky
- K. Abrams
- Gary K. Grunwald
Who trusts B. Mihaylova overall
Papers from B. Mihaylova's perspective
Ordered by how strongly the researchers B. Mihaylova trusts endorse each paper. Same corpus, a different order for every researcher.
- Smearing Estimate: A Nonparametric Retransformation Method
- Econometric Analysis of Count Data
- Robust Inference for Generalized Linear Models
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study (The Lancet)
- A bivariate zero-inflated negative binomial regression model for count data with excess zeros
- Microeconometrics Using Stata
- Estimating log models: to transform or not to transform? (Journal of Health Economics)
- Analysis of repeated measures data with clumping at zero
- Too much ado about two-part models and transformation? Comparing methods of modeling Medicare expenditures. (Journal of Health Economics)
- Extended Generalized Linear Models: Simultaneous Estimation of Flexible Link and Variance Functions
Their papers
- Review of Statistical Methods for Analysing Healthcare Resources and Costs (2010) — 739 citations
- 2023 ESC Guidelines for the management of cardiomyopathies. (2023) — 2,144 citations
- 2023 ESC Guidelines for the management of acute coronary syndromes. (2023) — 3,922 citations
- 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. (2019) — 4,665 citations
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. (2019) — 3,945 citations
- Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. (2015) — 1,285 citations
- The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials (2012) — 2,636 citations